USPTO serial 79238821
LEUCOSACCHARIDE
Reviewed by CopyMark Law Group
Reg. 5929117Status 709
- Filing date
- Status date
- Registration date
- Dec 10, 2019
- Examiner
- GANDARA, KEYLA MARIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEUCOSACCHARIDE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
JP
NITTO PHARMACEUTICAL INDUSTRIES, LTD.
JP
Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
NITTO PHARMACEUTICAL INDUSTRIES, LTD.
JP
Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
NITTO PHARMACEUTICAL INDUSTRIES, LTD.
JP
Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; other microorganism, namely, bacteria and bacteria powder for producing food, dietary supplements for humans or beverages; polysaccharides for producing food, dietary supplements for humans or beverages; chemical products for the fresh-keeping and preserving of food; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastics; gluten for the food industry | SECTION 71 - CANCELLED | — |
| 003 | Cosmetics; cosmetic soaps and detergents for household use; dentifrices; perfume and flavour materials, namely, food flavorings prepared from essential oils or polysaccharide sold as an integral component of essential oils derived from microorganisms; false nails; false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; incense | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; cotton swabs for medical use; dental materials, namely, dental adhesives; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies, namely, infant formula; food for babies; dietary supplements for animals | SECTION 71 - CANCELLED | — |
| 016 | Paper and cardboard; printed matter, namely, paper signs, books, manuals, curricula, newsletters, informational cards and brochures in the field of health | SECTION 71 - CANCELLED | — |
| 029 | Milk products excluding ice cream, ice milk and frozen yogurt; edible oils and fats; fresh, chilled, or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals, not live; processed meat products, namely, dried meat and chicken, meat, or fish croquettes, sausages, ham and bacon; processed seafood products other than blocks of boiled, smoked and then dried bonitos, dried pieces of agar jelly, flakes of dried fish meat, fishmeal for human consumption, edible shavings of dried kelp, sheets of dried laver, dried brown alga, dried edible seaweed and toasted sheets of laver, namely, tinned and processed fish; processed vegetables and fruits; protein for use as a food additive, namely, textured vegetable protein for use as a meat extender | SECTION 71 - CANCELLED | — |
| 030 | Tea; coffee roasted, powdered, granulated, or in drinks; cocoa roasted, powdered, granulated, or in drinks; confectionery made of sugar, sugar substitutes derived from microorganism, or sugar substitutes derived from polysaccharide; bread and buns; sandwiches; steamed buns stuffed with minced meat; hamburgers being sandwiches; pizzas; hot dogs being sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystal sugar not being confectionery; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flour | SECTION 71 - CANCELLED | — |
| 032 | Whey beverages; carbonated non-alcoholic drinks being refreshing beverages; fruit juices; vegetable juices being beverages; beer; extracts of hops for making beer | SECTION 71 - CANCELLED | — |
| 033 | Awamori being distilled rice spirits; sake substitute, namely, yellow rice wine; Japanese white liquor being shochu; Japanese sweet rice-based mixed liquor being shiro-zake; Sake; Japanese regenerated liquors being naoshi; Japanese shochu-based mixed liquor being mirin; western liquors in general; alcoholic fruit beverages; Japanese shochu-based mixed liquor beverages being chuhai; Chinese liquors in general; flavored liquors | SECTION 71 - CANCELLED | — |
| 035 | Advertising and publicity services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Noster Inc.
- Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
- Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
- Other trademarks owned by NITTO PHARMACEUTICAL INDUSTRIES, LTD.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 016
- Other trademarks in Class 029
- Other trademarks in Class 030
- Other trademarks in Class 032
- Other trademarks in Class 033
- Other trademarks in Class 035
- Similar marks named LEUCOSACCHARIDE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 26, 2026 | C71T | CANCELLED SECTION 71 | — |
| Dec 10, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 17, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 26, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 26, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 10, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 10, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 24, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 24, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 4, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 4, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 4, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 16, 2019 | MREI | NOTICE OF REINSTATEMENT E-MAILED | — |
| Aug 15, 2019 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Aug 15, 2019 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Aug 15, 2019 | CNCF | ACTION CONTINUING A FINAL - COMPLETED | — |
| Aug 12, 2019 | RGIA | REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED | — |
| Aug 12, 2019 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Aug 12, 2019 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Jul 19, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 5, 2019 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 18, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 18, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 18, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 7, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 5, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 25, 2018 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 25, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 4, 2018 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 4, 2018 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 28, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Sep 19, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 19, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 14, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 21, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |